Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy

Polifeprosan 20 with carmustine (GLIADEL(®)) polymer implant wafer is a biodegradable compound containing 3.85% carmustine (BCNU, bischloroethylnitrosourea) implanted in the brain at the time of planned tumor surgery, which then slowly degrades to release the BCNU chemotherapy directly into the brai...

Descripción completa

Detalles Bibliográficos
Autor principal: Kleinberg, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125766/
https://www.ncbi.nlm.nih.gov/pubmed/27920506
http://dx.doi.org/10.2147/PPA.S93020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125766/
https://www.ncbi.nlm.nih.gov/pubmed/27920506
http://dx.doi.org/10.2147/PPA.S93020

Ejemplares similares